The study authors focused on altering one of H5N1’s surface proteins, hemagglutinin, which contains the binding site that allows the virus to latch onto host cell receptors and kick-start infection.

This CTX–GM1 receptor interaction is central to the development of symptoms. Because of this, the researchers hypothesized that blocking this toxin with a binding protein would have protective effects ...